“Dr. Miguel Sierra-Hoffman, an associate professor of infectious disease at Baylor Scott & White Hospital and of pulmonary medicine at Texas A&M University, who has overseen the care of thousands of COVID patients at multiple hospitals, remains convinced that the embrace of outpatient treatments early on would have been a difference maker–and an economical one. ‘If we had given people aspirin, ivermectin, colchicine, and if they get complicated, a little dexamethasone, we could have saved the world with one dollar.’ For his part, Sen. Ron Johnson [R-Wis.] blames public health authorities for orchestrating a broader campaign against early treatment with repurposed drugs. ‘Rather than seriously consider evidence showing the potential of early treatments including ivermectin, your agencies prefer to mischaracterize, conflate and misconstrue anything that goes against the mainstream narrative and the financial interests of the pharmaceutical industry,’ he wrote in an October 2021 letter to Biden administration health officials.”
“Did Dismissals of Safe Outpatient Drugs Cause Needless Covid Deaths?” The Federalist, Feb. 2, 2022